Background Phospholipase A2 receptor antibodies (PLA2R-Ab) and thrombospondin type-1
domain-containing 7A antibodies (THSD7A-Ab) are present in 70–80% of patients with …

Background Antibodies against phospholipase A 2 receptor 1 (PLA 2 R1) are found in 80%
of patients with membranous nephropathy, and previous studies described three …

Background Glomerular M‐type phospholipase A2 receptor (PLA2R) is important for
diagnosing idiopathic membranous nephropathy (IMN). The relation between glomerular …

Membranous nephropathy (MN) remains the most common primary cause of nephrotic
syndrome in Europe and a common cause of end-stage renal failure. The reporting of …

Rationale & Objective Proteinuria and anti–phospholipase A 2 receptor 1 (anti-PLA 2 R1)
antibody titers are associated with primary membranous nephropathy (MN) outcomes. We …

Objectives This study aimed to establish time-resolved fluorescence immunoassays to
quantitatively detect the autoantibodies targeting different epitopes of M-type phospholipase …

Aim Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …

Circulating anti-phospholipase A2 receptor (PLA2R) antibodies have been identified as an
immunological marker of disease activity in patients with idiopathic membranous …

Background The optimal timing and duration of immunosuppressive therapy for idiopathic
membranous nephropathy (iMN) have been debated. This study aimed to evaluate whether …

Background Circulating autoantibodies against the M-type phospholipase A 2 receptor 1
(PLA 2 R1) are important biomarkers in membranous nephropathy (MN), supporting the …